These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15895885

  • 1. Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis.
    Nagy Z, Czirják L.
    Clin Exp Rheumatol; 2005; 23(2):165-72. PubMed ID: 15895885
    [Abstract] [Full Text] [Related]

  • 2. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ, Shin KC, Kang SW, Lee EB, Kim HA, Song YW.
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [Abstract] [Full Text] [Related]

  • 3. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
    Gonzalez-Lopez L, Rocha-Muñoz AD, Olivas-Flores EM, Garcia-Gonzalez A, Peguero-Gómez AR, Flores-Navarro J, Villa-Manzano AI, Zavaleta-Muñiz SA, Salazar-Paramo M, Mejía M, Juárez-Contreras P, Vazquez-Del Mercado M, Cardona-Muñoz EG, Trujillo-Hernández B, Nava-Zavala AH, Gamez-Nava JI.
    Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
    [Abstract] [Full Text] [Related]

  • 4. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C, Harding S, Khimdas S, Bonner A, Canadian Scleroderma Research group, Baron M, Pope J.
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [Abstract] [Full Text] [Related]

  • 5. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
    Heickendorff L, Parvez A, Bjerring P, Halkier-Sørensen L, Zachariae H.
    Acta Derm Venereol; 1991 Sep; 71(3):185-8. PubMed ID: 1678217
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease.
    La Montagna G, D'Angelo S, Valentini G.
    J Rheumatol; 2003 Oct; 30(10):2147-51. PubMed ID: 14528508
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
    Scheja A, Akesson A, Hørslev-Petersen K.
    Scand J Rheumatol; 1992 Oct; 21(1):5-9. PubMed ID: 1570489
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
    Simojoki M, Santala M, Risteli J, Risteli L, Kauppila A.
    Anticancer Res; 2000 Oct; 20(6C):4655-60. PubMed ID: 11205196
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
    Zachariae H, Halkier-Sørensen L, Heickendorff L.
    Acta Derm Venereol; 1989 Oct; 69(1):66-70. PubMed ID: 2563612
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.